These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 25790167
1. Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD. Footitt J, Mallia P, Durham AL, Ho WE, Trujillo-Torralbo MB, Telcian AG, Del Rosario A, Chang C, Peh HY, Kebadze T, Aniscenko J, Stanciu L, Essilfie-Quaye S, Ito K, Barnes PJ, Elkin SL, Kon OM, Wong WS, Adcock IM, Johnston SL. Chest; 2016 Jan; 149(1):62-73. PubMed ID: 25790167 [Abstract] [Full Text] [Related]
2. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Mallia P, Message SD, Gielen V, Contoli M, Gray K, Kebadze T, Aniscenko J, Laza-Stanca V, Edwards MR, Slater L, Papi A, Stanciu LA, Kon OM, Johnson M, Johnston SL. Am J Respir Crit Care Med; 2011 Mar 15; 183(6):734-42. PubMed ID: 20889904 [Abstract] [Full Text] [Related]
3. Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD. Zhu J, Mallia P, Footitt J, Qiu Y, Message SD, Kebadze T, Aniscenko J, Barnes PJ, Adcock IM, Kon OM, Johnson M, Contoli M, Stanciu LA, Papi A, Jeffery PK, Johnston SL. J Allergy Clin Immunol; 2020 Oct 15; 146(4):840-850.e7. PubMed ID: 32283204 [Abstract] [Full Text] [Related]
4. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Mallia P, Footitt J, Sotero R, Jepson A, Contoli M, Trujillo-Torralbo MB, Kebadze T, Aniscenko J, Oleszkiewicz G, Gray K, Message SD, Ito K, Barnes PJ, Adcock IM, Papi A, Stanciu LA, Elkin SL, Kon OM, Johnson M, Johnston SL. Am J Respir Crit Care Med; 2012 Dec 01; 186(11):1117-24. PubMed ID: 23024024 [Abstract] [Full Text] [Related]
5. Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease. Mallia P, Webber J, Gill SK, Trujillo-Torralbo MB, Calderazzo MA, Finney L, Bakhsoliani E, Farne H, Singanayagam A, Footitt J, Hewitt R, Kebadze T, Aniscenko J, Padmanaban V, Molyneaux PL, Adcock IM, Barnes PJ, Ito K, Elkin SL, Kon OM, Cookson WO, Moffat MF, Johnston SL, Tregoning JS. J Allergy Clin Immunol; 2018 Sep 01; 142(3):815-823.e6. PubMed ID: 29310905 [Abstract] [Full Text] [Related]
6. Antiviral immunity is impaired in COPD patients with frequent exacerbations. Singanayagam A, Loo SL, Calderazzo M, Finney LJ, Trujillo Torralbo MB, Bakhsoliani E, Girkin J, Veerati P, Pathinayake PS, Nichol KS, Reid A, Footitt J, Wark PAB, Grainge CL, Johnston SL, Bartlett NW, Mallia P. Am J Physiol Lung Cell Mol Physiol; 2019 Dec 01; 317(6):L893-L903. PubMed ID: 31513433 [Abstract] [Full Text] [Related]
7. Human rhinovirus infection and COPD: role in exacerbations and potential for therapeutic targets. Cafferkey J, Coultas JA, Mallia P. Expert Rev Respir Med; 2020 Aug 01; 14(8):777-789. PubMed ID: 32498634 [Abstract] [Full Text] [Related]
8. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Molyneaux PL, Mallia P, Cox MJ, Footitt J, Willis-Owen SA, Homola D, Trujillo-Torralbo MB, Elkin S, Kon OM, Cookson WO, Moffatt MF, Johnston SL. Am J Respir Crit Care Med; 2013 Nov 15; 188(10):1224-31. PubMed ID: 23992479 [Abstract] [Full Text] [Related]
9. Oxidative Stress Attenuates TLR3 Responsiveness and Impairs Anti-viral Mechanisms in Bronchial Epithelial Cells From COPD and Asthma Patients. Menzel M, Ramu S, Calvén J, Olejnicka B, Sverrild A, Porsbjerg C, Tufvesson E, Bjermer L, Akbarshahi H, Uller L. Front Immunol; 2019 Nov 15; 10():2765. PubMed ID: 31849956 [Abstract] [Full Text] [Related]
10. Decreased Histone Deacetylase 2 (HDAC2) in Peripheral Blood Monocytes (PBMCs) of COPD Patients. Tan C, Xuan L, Cao S, Yu G, Hou Q, Wang H. PLoS One; 2016 Nov 15; 11(1):e0147380. PubMed ID: 26809128 [Abstract] [Full Text] [Related]
11. Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD. Quint JK, Donaldson GC, Goldring JJ, Baghai-Ravary R, Hurst JR, Wedzicha JA. Chest; 2010 Apr 15; 137(4):812-22. PubMed ID: 19837822 [Abstract] [Full Text] [Related]
12. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Wilkinson TMA, Hurst JR, Perera WR, Wilks M, Donaldson GC, Wedzicha JA. Chest; 2006 Feb 15; 129(2):317-324. PubMed ID: 16478847 [Abstract] [Full Text] [Related]
13. Quercetin prevents rhinovirus-induced progression of lung disease in mice with COPD phenotype. Farazuddin M, Mishra R, Jing Y, Srivastava V, Comstock AT, Sajjan US. PLoS One; 2018 Feb 15; 13(7):e0199612. PubMed ID: 29975735 [Abstract] [Full Text] [Related]
14. Experimental rhinovirus infection in COPD: implications for antiviral therapies. Gunawardana N, Finney L, Johnston SL, Mallia P. Antiviral Res; 2014 Feb 15; 102():95-105. PubMed ID: 24370732 [Abstract] [Full Text] [Related]
16. MicroRNA-223 controls the expression of histone deacetylase 2: a novel axis in COPD. Leuenberger C, Schuoler C, Bye H, Mignan C, Rechsteiner T, Hillinger S, Opitz I, Marsland B, Faiz A, Hiemstra PS, Timens W, Camici GG, Kohler M, Huber LC, Brock M. J Mol Med (Berl); 2016 Jun 15; 94(6):725-34. PubMed ID: 26864305 [Abstract] [Full Text] [Related]
17. Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease. Mallia P, Message SD, Contoli M, Gray K, Telcian A, Laza-Stanca V, Papi A, Stanciu LA, Elkin S, Kon OM, Johnson M, Johnston SL. Respir Med; 2014 Jan 15; 108(1):78-85. PubMed ID: 24099891 [Abstract] [Full Text] [Related]
19. [Respiratory virus infections and inflammatory cytokines in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease]. Zhao CL, Huang JW, Zhang L, Zhang QR, Li QM, Zhou M. Zhonghua Jie He He Hu Xi Za Zhi; 2018 Dec 12; 41(12):942-948. PubMed ID: 30522191 [Abstract] [Full Text] [Related]